Hanmi Pharm. Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was KRW 674.94 million compared to KRW 989.73 million a year ago. Net income was KRW 13,979.64 million compared to KRW 18,422.39 million a year ago. Basic earnings per share from continuing operations was KRW 1,101.9608 compared to KRW 1,450 a year ago. Basic earnings per share was KRW 1,101.9608 compared to KRW 1,450 a year ago.
For the six months, sales was KRW 3,245.06 million compared to KRW 1,837.73 million a year ago. Net income was KRW 57,127.37 million compared to KRW 37,937.39 million a year ago. Basic earnings per share from continuing operations was KRW 4,500.9804 compared to KRW 2,986.2745 a year ago. Basic earnings per share was KRW 4,500.9804 compared to KRW 2,986.2745 a year ago.